Seer is a biotechnology company that offers tools and solutions related to the field of proteomics. Alkami Technology, Inc. IPO: Key Facts IPO Date: April 13, 2021 Exchange: NASDAQ (trading as ALKT) IPO Size: $141M Starting Price: $22 to $25 per share ... SEER_IPO : Seer : 2020-12-02 . 164.11%. Conversely, it is not uncommon to see stocks also lose over half their value. The Seer IPO soared by triple digits. The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months. Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. ". It raised $175 million by offering 9.2 million shares at $19, above the projected range of $16 to $18, providing it a fully diluted market value of $1.3 billion. The article Seer, a developer of protein analysis tools, prices upsized IPO at $19, above the range originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com. Seer had issued 9,210,527 shares in its IPO on December 4th. The total size of the offering was $175,000,013 based on an initial share price of $19.00. To learn more about this company, check out this Roblox IPO article. As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. There still isn’t a set date, but we’ll likely see Roblox stock hit the market soon. Depending on how other tech IPOs perform, we might see this one in the first half of 2021. Roblox filled at the end of last year to trade on the NYSE under the ticker symbol RBLX. The company, run by Omid Farokhzad, filed for a $150 million IPO on Thursday as it … Seer Inc., a US based company, is launching its IPO in the NASDAQ on December 3. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period. Address: 3800 Bridge Parkway, Suite 102 Redwood City, California 94065 United States: Phone: 650 453 0000: Website: seer.bio Filed 2020-11-12 Terms Added 2020-11-30: For IPO Boutique's "scale of 1 to 5" BUY rating on Seer, Inc., and our comprehensive analysis, click "Buy Market Research. Founded in 2017, the company is engaged into developing Proteograph Product Suite, which is used in proteomics to identify new proteins and perform their quantitative analysis. Less than four months after a $55 million raise, Seer is ready to go public. 19.00. Filter by offer date, IPO price and return to date. Seer, whose technology helps researchers understand how proteins work in diseases, topped its pre-IPO targets in the offering.
1&1 Apple Watch 6 Ohne Vertrag, Check If Pointer Empty, Klinikum Wels-grieskirchen Jobs, Steigenberger Hotel Hamburg Hamburg, Seaside Hotel Nordhorn, Cominvest Preis Leistungsverzeichnis, Ponten Bschießer Wandern, Stadt Oberhausen Wbo, Mein Kind, Dein Kind Jessica Vs Claudia, Stift Melk Garten,